Senate Aging Committee
U.S. Government: Elected Officials | U.S. Congressional Committees
Recent News About Senate Aging Committee
-
The Senate Special Committee on Aging will hold a hearing March 11 about China's control over America's drug supply chain. Lawmakers aim to address concerns about reliance on foreign-made pharmaceuticals affecting seniors' health.
-
The Senate Special Committee on Aging will hold a hearing examining China's influence over America's drug supply chain. Lawmakers aim to address concerns about foreign dependence for essential medications used by older Americans.
-
Chairman Rick Scott and Senator Mark Kelly have introduced a bipartisan resolution to designate March 5 as National Slam the Scam Day.
-
Chairman Rick Scott’s CLEAR LABELS Act has gained support in both chambers of Congress, with Representative Rich McCormick leading the initiative in the House of Representatives.
-
Chairman Rick Scott and Ranking Member Kirsten Gillibrand of the U.S. Senate Special Committee on Aging have sent a letter to the chief executive officers of CVS, Walgreens, and Walmart.
-
Senator Rick Scott, chairman of the U.S. Senate Special Committee on Aging, led a hearing titled “From Regulator to Roadblock: How FDA Bureaucracy Stifles Innovation.” The session focused on how regulatory processes and changing standards at the...
-
Chairman Rick Scott led a hearing of the Senate Special Committee on Aging focused on how regulatory processes at the Food and Drug Administration (FDA) may delay access to treatments for rare diseases.
-
Chairman Rick Scott and Ranking Member Kirsten Gillibrand will lead a Senate Aging Committee hearing on February 26 to examine the Food and Drug Administration’s regulatory processes and their impact on patient access to innovative therapies,...
-
The Senate Special Committee on Aging will hold a hearing on February 26, 2026, to discuss the regulatory processes of the Food and Drug Administration (FDA) and their impact on patient access to therapies, especially for those with rare diseases.
-
Chairman Rick Scott and Ranking Member Kirsten Gillibrand of the Senate Special Committee on Aging have sent a letter to Department of War Secretary Pete Hegseth, seeking information about efforts to secure the U.S. pharmaceutical supply chain for...
-
Chairman Rick Scott of the U.S. Senate Special Committee on Aging will hold a hearing on February 26, 2026, to examine how Food and Drug Administration (FDA) regulatory processes may delay access to therapies for patients, especially those with...
-
Senator Rick Scott, chairman of the U.S. Senate Special Committee on Aging, led a hearing titled “Doctors are Out: How Washington Rules Drove Doctors from Medicine.” The session examined how federal regulations are contributing to physician...
-
Chairman Rick Scott and Ranking Member Kirsten Gillibrand of the U.S. Senate Special Committee on Aging will hold a hearing on Wednesday, February 11, to address how federal regulations and administrative burdens are contributing to physician...
-
The Senate Special Committee on Aging will hold a hearing on Wednesday, February 11, 2026, to discuss how federal regulations and administrative burdens are contributing to physician burnout and worsening workforce shortages in healthcare.
-
Chairman Rick Scott and Ranking Member Kirsten Gillibrand have introduced the Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act, which aims to require country of origin labeling...
-
Chairman Rick Scott of the Senate Special Committee on Aging led a hearing in Washington, D.C., focusing on the risks associated with America's reliance on foreign-manufactured generic drugs.
-
Senator Rick Scott, chairman of the U.S. Senate Special Committee on Aging, led a hearing titled “Truth in Labeling: Americans Deserve to Know Where Their Drugs Come From.” The session focused on concerns about the United States’ reliance on...
-
The Senate Special Committee on Aging will hold a hearing on January 29, 2026, to address transparency issues related to the country of origin labeling for generic drugs and active pharmaceutical ingredients sold in the United States.
-
Senator Rick Scott, chairman of the U.S. Senate Special Committee on Aging, and Ranking Member Kirsten Gillibrand will lead a hearing on Thursday, January 29, focusing on transparency in the labeling of generic drugs sold in the United States.
-
Senator Rick Scott, who serves as chair of the Senate Special Committee on Aging, led a hearing focused on international scams targeting older Americans.